A high anti-dsDNA level depends on the specific test your lab used, but on one of the most common assays, a result of 36 IU/mL or above is considered positive, while anything under 27 IU/mL is negative. Results between 27 and 35 IU/mL fall into a borderline zone. These numbers can be misleading, though, because different testing methods use completely different scales, and what counts as “high” at one lab may not match another.
Why the Numbers Vary Between Labs
There is no single universal cutoff for a high anti-dsDNA result. The threshold depends entirely on which testing method your lab used. One widely used enzyme-linked test sets its positive cutoff at 36 IU/mL. Another manufacturer’s version of the same type of test considers anything under 100 IU/mL normal. A third sets its negative threshold at just 15 IU/mL. All three measure the same antibody, and all three report results in IU/mL, yet their cutoffs differ dramatically.
This inconsistency exists because each test kit uses slightly different materials to capture the antibody, and those materials bind with different strengths. The World Health Organization created a standardized reference serum called Wo/80 to help calibrate these tests against each other, but even with that calibration, the agreement between different assays remains only moderate. Your lab report should include a reference range printed alongside your result. That range, not a number you found online, is the one that applies to your specific test.
Common Testing Methods and What They Measure
Three main techniques are used to detect anti-dsDNA antibodies, and each has trade-offs between sensitivity and specificity. The enzyme-linked immunoassay (ELISA) is the most common screening test. It gives a numerical result and is easy to run in high volumes, but studies show poor consistency between different ELISA kits from different manufacturers. A newer method called chemiluminescent immunoassay performs similarly to ELISA for general diagnosis but may be better at predicting kidney involvement in lupus.
The Crithidia luciliae immunofluorescence test (CLIFT) works differently. It uses a single-celled organism whose DNA structure allows very precise detection of anti-dsDNA antibodies. This makes it highly specific, meaning a positive result is very reliable. The downside is lower sensitivity: it can miss cases, especially early ones, so it’s not ideal for screening. Results are also read by a technician under a microscope rather than by a machine, which introduces some variability. A third method, the Farr assay, was long considered the gold standard for both sensitivity and specificity, but it requires radioactive materials and has largely been phased out of routine clinical use.
What High Levels Usually Mean
Anti-dsDNA antibodies are most strongly associated with systemic lupus erythematosus (SLE). About 60% of people with lupus test positive for these antibodies at some point during their disease. In the current classification criteria used to diagnose lupus, a positive anti-dsDNA result on a highly specific test carries 6 out of the 10 points needed for classification, making it one of the single most heavily weighted laboratory findings.
But a positive result doesn’t automatically mean lupus. In one study of 212 patients who tested positive for anti-dsDNA, 41.5% had conditions other than SLE. The non-lupus diagnoses included other rheumatological disorders (33% of the non-SLE group), infections such as tuberculosis (12%), and cancers including lymphoma and thymoma (7%). Autoimmune hepatitis, antiphospholipid syndrome, and sarcoidosis also appeared. Very high results above 800 IU/mL were rare in non-lupus conditions but did occur, particularly in autoimmune hepatitis.
Higher Levels and Kidney Risk
For people already diagnosed with lupus, the absolute level of anti-dsDNA matters less than the direction it’s moving. Rising levels are a warning sign, particularly for the kidneys. In two clinical trials, patients whose antibody levels remained stable or climbed had renal flare rates of about 20%, compared to just 3 to 4% in patients whose levels dropped. A 50% reduction in anti-dsDNA levels was associated with roughly a 52% reduction in the risk of a kidney flare.
This connection between rising antibodies and kidney inflammation is one reason doctors track anti-dsDNA over time rather than reacting to a single number. A result of 200 IU/mL in someone whose previous result was 50 IU/mL is more concerning than a stable reading of 200 IU/mL that hasn’t changed in months.
Antibody Surges and Disease Flares
A rapid spike in anti-dsDNA levels is one of the strongest laboratory predictors of an upcoming lupus flare. Research shows that a surge in antibody titer carries about a six-fold increase in the odds of a severe flare within the following six months. One study found that 89% of disease flares in a group of 72 lupus patients were preceded by a rise in anti-dsDNA levels, typically 8 to 10 weeks before symptoms appeared.
The symptoms that accompany or follow these rises can include joint pain, skin rashes, fatigue, fevers, mouth sores, and swelling. When kidney involvement is present, protein in the urine and fluid retention are common signs. Because the antibody increase often precedes the clinical symptoms by weeks, regular monitoring gives doctors a window to intervene early.
How to Read Your Own Results
Start with the reference range printed on your lab report. If your result falls below that range, the test is negative regardless of the specific number. If it falls in a borderline zone, a repeat test or a different testing method can help clarify. If it’s clearly positive, the result needs to be interpreted alongside your symptoms, physical exam findings, and other blood work like complement levels (C3 and C4) and a general antinuclear antibody test.
A single positive anti-dsDNA result in someone with no symptoms is not a diagnosis of anything. Likewise, a very high number in someone already being treated for lupus may prompt a change in therapy, while the same number in someone with stable disease and no symptoms may simply be monitored. Context matters more than the number itself, and the trend over time matters more than any single reading.